اگلا

آٹو پلے

Chemotherapy Toxicity Considerations in Soft Tissue Sarcoma

0 مناظر • 07/18/23
بانٹیں
ایمبیڈ
administrator
administrator
سبسکرائبرز
0

The panelists, Brian Van Tine, MD, PhD; Robin Jones, MD, MRCP; Andrew Wagner, MD, PhD; Lor Randall, MD, FACS; Shreyaskumar Patel, MD; and Jonathan Trent, MD, PhD; discuss the factors they consider when balancing the risks and benefits of chemotherapy treatment in soft tissue sarcoma.

مزید دکھائیں
0 تبصرے sort ترتیب دیں
فیس بک کے تبصرے

اگلا

آٹو پلے